Semaglutide exerts positive inotropic effects in the human atrium.
Anno:
2024
Semaglutide is currently an approved drug to treat diabetes II and obesity. It can increase release of insulin and inhibit release of glucagon in the pancreas. It is unknown whether it exerts positive inotropic effects in the human heart. Therefore, we studied in isolated electrically stimulated 1 Hz right…